PolypDx™ for Patients.
Dr. Haili Wang, colorectal surgeon at the University of Alberta Hospital and Co-Founder of Metabolomic Technologies Inc. speaks to the advantages of PolypDx™, the first and only urine screen for detecting pre-cancerous polyps for Colorectal Cancer.
How does it work?
PolypDx™ is a urine-based screening test. Only a small amount of urine is required. The test detects a distinct metabolomic fingerprint specific to precancerous, adenomatous polyps.
DOCTOR PRESCRIBES POLYPDX™ TEST KIT.
TEST KIT IS SHIPPED DIRECTLY TO YOUR DOOR.
COLLECT URINE SAMPLE AND RETURN TEST KIT.
TEST RESULTS ARE RETURNED TO DOCTOR.
IF RESULTS ARE POSITIVE, A COLONOSCOPY IS RECOMMENDED.
Interpreting the results.
Once screened, patients with a positive result and presenting a risk of adenomatous polyps can be directed to a colonoscopy during which the adenomatous polyps can be removed, thus preventing the progression into Colorectal Cancer. Those patients with negative results can continue with regular repeated screening with PolypDx™, and give themselves peace of mind.